telephone number: +46 46 222 83 03 2 13 Abstract 14 Myricetin, a flavonoid found in the plant kingdom, has previously been identified as a food 15 molecule with beneficial effects against obesity. This property has been related with its potential 16 to inhibit lipase, the enzyme responsible of fat digestion. In this study we investigate the 17 interaction between myricetin and lipase under simplified intestinal conditions from a colloidal 18 point of view. The results show that myricetin form aggregates in aqueous medium and under 19 simplified intestinal condition, where it was found that lipase is in its monomeric form. Although 20 lipase inhibition by myricetin at a molecular level has been reported previously, the results of this 21 study suggest that myricetin aggregates inhibit lipase by a sequestering mechanism as well. The 22 size of these aggregates was determined to be in the range of a few nm to >200 nm.
1. Introduction24 Myricetin is a polyphenol member of the flavonoids family. It is commonly found in the plant 25 kingdom and present in a diversity of foods such as berries, teas and wines (1, 2). Besides its anti-26 oxidant properties, myricetin has been claimed to display several beneficial activities such as 27 analgesic, anti-inflammatory, antitumor, and antidiabetic activities (3). As other compounds of 28 the same family, myricetin can inhibit several digestive enzymes (4), for example lipase, the main 29 enzyme in fat digestion. This enzyme has been intensely studied because of its relation to anti-30 obesity treatments (5, 6). In addition to myricetin, some other flavonoids have been proposed to 31 be lipase inhibitors, for example it has been shown that quercetin can bind to lipase near the 32 active site (7). Many of these studies are based on molecular docking, where the flavonoids are 33 considered soluble compounds and the interaction happens at the molecular level. On the other 3 34 hand, other studies have shown that some flavonoids can aggregate in aqueous media and inhibit 35 proteins by a sequestering mechanism (8, 9).36 The myricetin content in some edible products is higher than its aqueous solubility, for instance 37 green tea has been reported to contain approximately 6 μg of myricetin per ml (10), whereas the 38 aqueous solubility is <1.5 μg/mL (11). Thus, it is likely that the majority of the molecules are not 39 present as dissolved compounds and that they could be present as, for instance, supramolecular 40 aggregates. The presence of myricetin aggregates in solution, can influence enzymatic assays. 41 Bustos et al. (2019), have shown that the presence of phenolic aggregates can affect the 42 reproducibility of lipase assays. Pohjala et al. (2012) have also discussed this issue and suggested 43 that this disturbance can be reduced by adding surfactants that reduce aggregate formation 44 when using enzymatic assays in the presence of flavonoids.45 A challenge to applications trying to harness the many beneficial effects of myricetin is its low 46 bioavailability; 10% absolute ...